CLNN
Clene Inc.
There isn't enough reported data to score CLNN yet.
CLNN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Unavailable | |
| Unavailable |
CLNN's revenue is currently healthy, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
CLNN PE Valuation
CLNN has no meaningful PE right now: it lost money over the past year.
CLNN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CLNN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CLNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.66 | +$1.01 |
| Q2 2026 | -$3.56 | +$0.48 |
| Q1 2026 | -$3.26 | +$1.06 |
| Q4 2025 | -$2.66 | +$3.37 |
| Q3 2025 | -$3.67 | +$2.35 |
| Q2 2025 | -$4.04 | +$1.16 |
| Q1 2025 | -$4.32 | +$5.62 |
| Q4 2024 | -$6.03 | +$5.11 |
CLNN is still losing money, but far less than before: $2.66 per share over the past year, against $17.63 at its worst in early 2021.
CLNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $56K | +273% |
| Q2 2026 | $90K | +233% |
| Q1 2026 | $15K | -81% |
| Q4 2025 | $77K | -15% |
| Q3 2025 | $15K | -83% |
| Q2 2025 | $27K | -70% |
| Q1 2025 | $81K | +11% |
| Q4 2024 | $91K | -46% |
CLNN's revenue is recovering but still below its 2023 peak: $56,000 last quarter, up 273% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11334% | +26319 points |
| Q2 2026 | -5941% | +15777 points |
| Q1 2026 | -13740% | -8708 points |
| Q4 2025 | -9734% | -223 points |
| Q3 2025 | -37653% | -28671 points |
| Q2 2025 | -21719% | -13597 points |
| Q1 2025 | -5032% | +7615 points |
| Q4 2024 | -9511% | -3670 points |
CLNN's operating margin was −11334% last quarter, up 26319 points from the same quarter a year ago.
CLNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.7M | -$665K |
| Q1 2026 | -$4.5M | +$483K |
| Q4 2025 | -$4.8M | +$39K |
| Q3 2025 | -$4M | -$979K |
| Q2 2025 | -$4.7M | +$1.6M |
| Q1 2025 | -$5M | +$2.1M |
| Q4 2024 | -$4.9M | +$2.3M |
| Q3 2024 | -$3M | +$3.8M |
CLNN has burned cash in almost every quarter: −$18M over the past year, against −$18M the year before.
CLNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +18% | +2.3M shares |
| 1 year | +43% | +4.4M shares |
| 3 years | +128% | +8.2M shares |
| 5 years | +319% | +11.2M shares |
| Available history | +323% | +11.2M shares |
CLNN has 15M diluted shares, up 43% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
CLNN Net Leverage
CLNN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 36.9 | Neutral |
CLNN's weekly RSI is 44 (neutral) and its Stochastic is 37 (neutral).
CLNN PE vs Healthcare Sector
| Metric | CLNN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
CLNN has no meaningful PE right now: it lost money over the past year.
CLNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.88 | 3.1% above |
| 20 week MA | $4.47 | 11% below |
| 50 week MA | $5.23 | 24% below |
| 100 week MA | $5.19 | 23% below |
| 200 week MA | $8.40 | 52% below |
CLNN has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CLNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $209.2 | $229.0 | +9.5% |
| 2021 | $229.0 | $87.4 | -62% |
| 2022 | $87.4 | $20.2 | -77% |
| 2023 | $20.2 | $5.93 | -71% |
| 2024 | $5.93 | $4.99 | -16% |
| 2025 | $4.99 | $6.25 | +25% |
| 2026 YTD | $6.25 | $4.00 | -36% |
CLNN has finished lower in four of the last six years. It's down 36% so far in 2026.